FindTrial
Sign In

Blockade of the renin-angiotensin system in kidney transplant patients with the presence of renal progenitor cells in urine: randomized clinical trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518723-30-01
Acronym
PRONE
Enrollment
180
Registered
2024-10-16
Start date
2024-10-16
Completion date
Unknown
Last updated
2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal transplant patients

Brief summary

No primary endpoint

Detailed description

No secondary endpoint

Interventions

DRUGValsartan STADA 80 mg Filmtabletten

Sponsors

Bellvitge University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
No primary endpoint—

Secondary

MeasureTime frame
No secondary endpoint—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026